R Squared Ltd Makes New $41,000 Investment in Viemed Healthcare, Inc. (NASDAQ:VMD)

R Squared Ltd bought a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,076 shares of the company’s stock, valued at approximately $41,000.

Several other hedge funds have also recently bought and sold shares of VMD. National Bank of Canada FI lifted its stake in shares of Viemed Healthcare by 91.2% in the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after buying an additional 1,596 shares during the period. Perkins Coie Trust Co bought a new stake in shares of Viemed Healthcare in the third quarter valued at about $73,000. PDT Partners LLC bought a new stake in shares of Viemed Healthcare in the third quarter valued at about $78,000. Walleye Capital LLC bought a new stake in shares of Viemed Healthcare in the third quarter valued at about $87,000. Finally, SG Americas Securities LLC bought a new stake in shares of Viemed Healthcare in the third quarter valued at about $89,000. 74.24% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Viemed Healthcare

In other Viemed Healthcare news, Director Nitin Kaushal sold 30,000 shares of Viemed Healthcare stock in a transaction on Monday, November 11th. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00. Following the completion of the sale, the director now owns 126,843 shares of the company’s stock, valued at approximately $1,212,619.08. The trade was a 19.13 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the sale, the director now directly owns 107,706 shares of the company’s stock, valued at $999,511.68. This represents a 25.19 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 72,256 shares of company stock valued at $674,739 over the last quarter. Corporate insiders own 20.00% of the company’s stock.

Viemed Healthcare Stock Down 1.4 %

NASDAQ VMD opened at $8.19 on Monday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The firm has a 50-day simple moving average of $8.32 and a 200 day simple moving average of $8.06. Viemed Healthcare, Inc. has a twelve month low of $6.21 and a twelve month high of $10.44. The stock has a market cap of $318.92 million, a PE ratio of 30.33 and a beta of 1.47.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The firm had revenue of $58.00 million during the quarter.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.